The effect of melatonin in patients with fibromyalgia: A pilot study

Clinical Rheumatology

Volumn 19, Issue 1, 2000, Pages 9-13

  Citera, G ^b   Arias, M A ^b   Maldonado Cocco, José A ^a   Lazaro M A ^b   Rosemffet, M G ^b   Brusco, L I ^b   Scheines, E J ^b   Cardinalli, D P ^b  

^a IREP   (Argentina)

^b NONE

Author keywords

Fibromyalgia; Melatonin; Pathogenesis; Therapy

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; MELATONIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; FATIGUE; FEMALE; FIBROMYALGIA; HUMAN; PAIN ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; SLEEP DISORDER;

ADMINISTRATION, ORAL; ADULT; AGED; ANTICONVULSANTS; FATIGUE SYNDROME, CHRONIC; FEMALE; FIBROMYALGIA; HUMANS; MELATONIN; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PILOT PROJECTS; SLEEP DISORDERS; TREATMENT OUTCOME;

EID: 0034100164     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670050003     Document Type: Article

References (30)

1. Burckhardt CS, Clarck SR, Bennett RM. Fibromyalgia and quality of life: a comparative analysis. J Rheumatol 1993;20:457-9.
2. Moldofsky H, Searisbrick P, England R, Smythe N. Musculoskeletal symptoms and non-REM sleep disturbance in patients with 'fibrositis syndrome' and healthy subjects. Psychosom Med 1975;37:341-51.
3. Lund N, Bengstssom A, Thorberg P. Muscle tissue oxygen pressure in primary fibromyalgia. Scand J Rheumatol 1986;15:165-73.
4. Valroy H, Helle R, Forre O, Kass E, Terenius L. Elevated CSF levels of substance 9 and high incidence of Raynaud's phenomenon in patients with fibromyalgia. New features for diagnosis. Pain 1988;32:21-6.
5. Bennett RM, Clarck SR, Campbell SM, Burckhardt CS. Low levels of somatomedia C in patients with the fibromyalgia syndrome: a possible link between sleep and muscle pain. Arthritis Rheum 1992;35:1113-6.
6. Mountz JM, Bradley LA, Modell JG, et al. Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate muscles are associated with low pain threshold levels. Arthritis Rheum 1995;38:926-38.
7. Russell IJ, Michalek JE, Vipraio GA, Fletcher EM, Wall K. Serum amino acids in fibrositis/fibromyalgia syndrome. J Rheumatol 1989;19:158-63.
8. Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC. Plasma tryptophan and other amino acids in primary fibromyalgia. A controlled study. J Rheumatol 1992;19:90-4.
9. Carette S, Oakson G, Buimont Ch, Steriade L. Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia. Arthritis Rheum 1995;38:1211-7.
10. Moldofsky H, Lue FA, Mously C, Roth-Schachter B, Reynolds WJ. The effect of zoldipen in patients with fibromyalgia: a dose ranging double-blind, placebo controlled, modified crossover study. J Rheumatol 1996;23:529-33.
11. Grönblad M, Nykanen J, Konttinen Y, Jarvinen E, Helve T. Effect of zopiclone on sleep quality, morning stiffness, widespread tenderness and pain and general discomfort in primary fibromyalgia patients. A double-blind randomized trial. Clin Rheumatol 1993;12:186-91.
12. Hench PK, Cohen R, Mitler MM. Fibromyalgia: effects of amitriptyline, temazepan and placebo on pain and sleep [abstr]. Arthritis Rheum 1989 (suppl)32:S47.
13. Reiter RJ. The pineal gland from last to first. The Endocrinologist 1993;3:425-31.
14. Reiter RJ. Melatonin: that ubiquitously acting pineal hormone. News Physiol Ser 1991;6:223-7.
15. Dawson D, Encel N. Melatonin and sleep in humans. J Pineal Res 1993;15:1-12.
16. Fainstein I, Bonetto AJ, Brusco LI, Cardinalli DP. Effects of melatonin in elderly patients with sleep disturbance. A pilot study. Curr Ther Res 1997;58:990-1000.
17. Almay BG, von Knorring L, Wetterberg L. Melatonin in serum and urine in patients with idiopathic pain syndromes. Psychiatr Res 1987;22:179-91.
18. Press J, Phillip M, Neuman L, et al. Normal melatonin levels in patients with fibromyalgia syndrome. J Rheumatol 1998;25:551-5.
19. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990;33:160-72.
20. Bojkowski CJ, Arendt J. Factors influencing urinary 6-sulphatoxymelatonin, a major melatonin metabolite in normal subjects. Clin Endocrinol 1990;33:435-44.
21. Cathey MA, Wolfe F, Kleinheksal SM. Functional ability and health status in patients with fibromyalgia. Arthritis Care Res 1989;1:85-98.
22. Wolfe F, Hanley DJ, Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 1996;23:1407-17.
23. Yunus MB, Masi AT, Aldag JC. Short term effects of ibuprofen in primary fibromyalgia syndrome: a double-blind, placebo controlled trial. J Rheumatol 1989;16:527-32.
24. Russell IJ, Fletcher EM, Michalek JE, McBroom PC, Hester GG. Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam, a double-blind, placebo controlled study. Arthritis Rheum 1991;34:552-60.
25. Goldenberg DL, Felson DT, Dinerman H. A randomized, controlled trial of amitriptyline in the treatment of patients with fibromyalgia. Arthritis Rheum 1986;29:1371-7.
26. Bennett RM, Gatter RA, Campbell SM, et al. A comparison of cyclobenzaprine and placebo in the management of fibrositis. Arthritis Rheum 1988;31:1535-42.
27. Fossaluzza V, De Vita S. Combined therapy with cyclobenzaprine and ibuprofen in primary fibromyalgia syndrome. Int J Clin Pharmacol Res 1992;12:99-102.
28. Messing RB, Lytle LD. Serotonin containing neurons: their possible role in pain and analgesia. Pain 1977;4:1-21.
29. Hrycaj P, Stratz T, Mennet P, Muller W. Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome. A preliminary study. J. Rheumatol 1996;23:1418-23.
30. Brzezinski A. Melatonin in humans. N Engl J Med 1997;336:186-95.